| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update JS Smolen, RBM Landewé, JWJ Bijlsma, GR Burmester, M Dougados, ... Annals of the rheumatic diseases 79 (6), 685-699, 2020 | 2652 | 2020 |
| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the rheumatic diseases 76 (6), 978-991, 2017 | 1860 | 2017 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18, 2023 | 598 | 2023 |
| ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update S Ramiro, E Nikiphorou, A Sepriano, A Ortolan, C Webers, X Baraliakos, ... Annals of the rheumatic diseases 82 (1), 19-34, 2023 | 396 | 2023 |
| Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from … JC Branco, AM Rodrigues, N Gouveia, M Eusébio, S Ramiro, ... RMD open 2 (1), e000166, 2016 | 345 | 2016 |
| Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations C Duftner, C Dejaco, A Sepriano, L Falzon, WA Schmidt, S Ramiro RMD open 4 (1), e000612, 2018 | 303 | 2018 |
| Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis A Sepriano, A Kerschbaumer, JS Smolen, D Van Der Heijde, ... Annals of the rheumatic diseases 79 (6), 760-770, 2020 | 265 | 2020 |
| Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of … A Kerschbaumer, A Sepriano, JS Smolen, D van der Heijde, M Dougados, ... Annals of the rheumatic diseases 79 (6), 744-759, 2020 | 242 | 2020 |
| Axial spondyloarthritis V Navarro-Compán, A Sepriano, B El-Zorkany, D van der Heijde Annals of the rheumatic diseases 80 (12), 1511-1521, 2021 | 185 | 2021 |
| Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort M Dougados, A Sepriano, A Molto, M van Lunteren, S Ramiro, ... Annals of the rheumatic diseases 76 (11), 1823-1828, 2017 | 176 | 2017 |
| Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management … A Sepriano, A Regel, D van der Heijde, J Braun, X Baraliakos, ... RMD open 3 (1), e000396, 2017 | 133 | 2017 |
| Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR … A Regel, A Sepriano, X Baraliakos, D van der Heijde, J Braun, ... RMD open 3 (1), e000397, 2017 | 110 | 2017 |
| Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis A Sepriano, R Landewé, D van der Heijde, J Sieper, N Akkoc, J Brandt, ... Annals of the rheumatic diseases 75 (6), 1034-1042, 2016 | 93 | 2016 |
| Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis A Sepriano, R Rubio, S Ramiro, R Landewé, D van der Heijde Annals of the rheumatic diseases 76 (5), 886-890, 2017 | 78 | 2017 |
| EpiReumaPt-the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology AM Rodrigues, N Gouveia, LP Costa, M Eusébio, S Ramiro, P Machado, ... Acta reumatologica portuguesa 40 (2), 110-124, 2015 | 77 | 2015 |
| Three handy tips and a practical guide to improve your propensity score models SA Bergstra, A Sepriano, S Ramiro, R Landewé RMD open 5 (1), e000953, 2019 | 59 | 2019 |
| Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis A Sepriano, A Kerschbaumer, SA Bergstra, JS Smolen, D Van Der Heijde, ... Annals of the rheumatic diseases 82 (1), 107-118, 2023 | 57 | 2023 |
| What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts A Sepriano, S Ramiro, D van der Heijde, F van Gaalen, P Hoonhout, ... Annals of the rheumatic diseases 79 (3), 324-331, 2020 | 54 | 2020 |
| Is treat-to-target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM) S Ramiro, RBM Landewé, D Van Der Heijde, A Sepriano, O FitzGerald, ... Annals of the rheumatic diseases 79 (4), 453-459, 2020 | 53 | 2020 |
| Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis A Kerschbaumer, A Sepriano, SA Bergstra, JS Smolen, D Van Der Heijde, ... Annals of the rheumatic diseases 82 (1), 95-106, 2023 | 52 | 2023 |
Helena CanhaoDean, Full Professor, Nova Medical School, Universidade NOVA de Lisboa在 nms.unl.pt 的电子邮件经过验证
Helena CanhaoDean, Full Professor, Nova Medical School, Universidade NOVA de Lisboa在 nms.unl.pt 的电子邮件经过验证
Sofia RamiroLeiden University Medical Center在 lumc.nl 的电子邮件经过验证